← Leaderboards
James C. Cloyd
University Of Minnesota Twin Cities
$3,915,311
Attributed
$5,481,797
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,248,379 · 12
FDA$233,418 · 1
By mechanism
R44$2,105,227 · 1
P50$1,710,095 · 2
R01$1,261,164 · 2
U54$289,199 · 1
M01$111,112 · 6
R13$5,000 · 1
Top collaborators
- Lisa D Coles3 shared
- Steven Prestrelski2 shared
- John Kinzell1 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Chester B Whitley$15,153,874
- Glenn Joseph Giesler$3,507,236
- Morayma Reyes$420,958
- R Scott McIvor$12,592,678
- Ilo E Leppik$456,299
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchDrug KineticsDosePharmaceutical PreparationsIntravenousPhenytoinExhibitsResearch DesignBasePharmacokineticsUrinalysisHuman Old Age (65+)Human SubjectOralAppearanceNeuraxisPlasmaFda ApprovedLeadBlood ChemistryEpilepsyIncidenceCarbamazepineControlled Clinical Trials
Grant awards (30)
ESETT Pharmacokinetic-Pharmacodynamic Study$327,246
R01 · FY2019 · NS
Auto-Injectable Diazepam Formulation for Rapid Treatment of Uncontrolled Seizures$793,851
R44 · FY2018 · NS
ESETT Pharmacokinetic-Pharmacodynamic Study$332,558
R01 · FY2018 · NS
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-lnflammatory Medications$58,891
U54 · FY2018 · NS · contact PI
Auto-Injectable Diazepam Formulation for Rapid Treatment of Uncontrolled Seizures$797,247
R44 · FY2017 · NS
ESETT Pharmacokinetic-Pharmacodynamic Study$367,942
R01 · FY2017 · NS
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-lnflammatory Medications$58,648
U54 · FY2017 · NS · contact PI
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-lnflammatory Medications$54,106
U54 · FY2016 · NS · contact PI
Auto-Injectable Diazepam Formulation for Rapid Treatment of Uncontrolled Seizures$514,129
R44 · FY2015 · NS
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-lnflammatory Medications$62,226
U54 · FY2015 · NS · contact PI
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-lnflammatory Medications$55,328
U54 · FY2014 · NS · contact PI
Indo-US Research Conference on Rare Diseases and Orphan Drugs$5,000
R13 · FY2010 · NS · contact PI
Phase I Study in Patients Supporting IV TPM for Neonatal Seizures (9/07, IND7899)$37,733
R01 · FY2009 · FD · contact PI
PHARMACOKINETICS AND SAFETY OF INTRAVENOUS TOPIRAMATE IN ADULT PATIENTS$7,684
M01 · FY2009 · RR · contact PI
Phase I Study in Patients Supporting IV TPM for Neonatal Seizures (9/07, IND7899)$195,685
R01 · FY2008 · FD · contact PI
PHARMACOKINETICS AND METABOLISM OF ANTIEPILEPTIC DRUGS IN ELDERLY PATIENTS$7,067
M01 · FY2008 · RR · contact PI
PHARMACOKINETICS AND METABOLISM OF ANTIEPILEPTIC DRUGS IN ELDERLY PATIENTS$18,329
M01 · FY2007 · RR · contact PI
Effects of age, gender and race on antiepileptic drugs$334,522
P50 · FY2006 · NS · contact PI
PHARMACOKINETICS AND METABOLISM OF ANTIEPILEPTIC DRUGS IN ELDERLY PATIENTS$21,879
M01 · FY2006 · RR · contact PI
Effects of age, gender and race on antiepileptic drugs$334,522
P50 · FY2005 · NS
PHARMACOKINETICS AND METABOLISM OF ANTIEPILEPTIC DRUGS IN ELDERLY PATIENTS$23,624
M01 · FY2005 · RR
Pharmacokinetics and Metabolism of Antiepileptic Drugs in Elderly Patients$32,529
M01 · FY2004 · RR
Effects of age, gender and race on antiepileptic drugs$297,610
P50 · FY2002 · NS
PHARMACOKINETICS AND METABOLISM OF ANTIEPILEPTICS IN ELDERLY PATIENTS$0
M01 · FY2002 · RR
PHARMACOKINETICS AND METABOLISM OF ANTIEPILEPTICS IN ELDERLY PATIENTS$0
M01 · FY2002 · RR
ANTIEPILEPTIC DRUG METABOLISM IN ELDERLY USING STABLE ISOTOPES$297,610
P50 · FY2001 · NS
PHARMACOKINETICS AND METABOLISM OF ANTIEPILEPTICS IN ELDERLY PATIENTS$0
M01 · FY2001 · RR
ANTIEPILEPTIC DRUG METABOLISM IN ELDERLY USING STABLE ISOTOPES$297,610
P50 · FY2000 · NS
ANTIEPILEPTIC DRUG METABOLISM IN ELDERLY USING STABLE ISOTOPES$148,221
P50 · FY2000 · NS
PHARMACOKINETICS AND METABOLISM OF ANTIEPILEPTICS IN ELDERLY PATIENTS$0
M01 · FY2000 · RR